We are live on !
Find out more
Tyro Capital Management Portfolio holdings
AUM
$564M
Turnover
56.25%
1-Year Est. Return
72.37%
This Fund
S&P 500
This Quarter Est. Return
-7.87%
1 Year Est. Return
+72.37%
3 Year Est. Return
+269.99%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$564M
AUM Growth
+$119M
(+27%)
Cap. Flow
+$188M
Cap. Flow % of AUM
Cap. Flow %
33.28%
Top 10 Holdings %
Top 10 Hldgs %
63.47%
Holding
32
New
17
Increased
13
Reduced
1
Closed
1
Avg Time Held
0.5
years
Top 10 Avg Time Held
1
year
Top 20 Avg Time Held
0.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Calumet
CLMT
|
+$51M |
| 2 |
Cipher Digital
CIFR
|
+$23.8M |
| 3 |
TeraWulf
WULF
|
+$22.7M |
| 4 |
Hut 8
HUT
|
+$21.3M |
| 5 |
Roundhill Memory ETF
DRAM
|
+$16.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Celsius Holdings
CELH
|
+$43.8M |
| 2 |
ARS Pharmaceuticals
SPRY
|
+$7.36M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 29.34% |
| 2 | Materials | 18.61% |
| 3 | Consumer Discretionary | 15.47% |
| 4 | Technology | 13.42% |
| 5 | Industrials | 9.27% |
Similar funds
SC
TCOT
CA
Tyro Capital Management's Q3 2026 Portfolio in Review
As of Q3 2026, Tyro Capital Management held 32 positions worth $564M, up 27% from $446M the previous quarter. Its ten largest holdings account for 63% of the portfolio.
Tyro Capital Management deployed $188M of net new capital in Q3 2026, opening 17 new positions and adding to 13 existing holdings. Its largest new stake was Calumet: 1,077,804 shares worth $56.5M.
By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 39% a quarter earlier, followed by Materials and Consumer Discretionary.
On the sell side, the largest reduction was ARS Pharmaceuticals, an estimated $7.36M trimmed.
- Tyro Capital Management's largest Q3 2026 buy was Calumet: 1,077,804 shares worth $56.5M.
- Tyro Capital Management added most to New Era Energy & Digital in Q3 2026, an estimated $11.9M increase.
- Tyro Capital Management's biggest Q3 2026 reduction was ARS Pharmaceuticals, cutting an estimated $7.36M.
- Tyro Capital Management fully exited Celsius Holdings in Q3 2026, selling an estimated $43.8M.
- Tyro Capital Management's ten largest holdings make up 63% of its $564M portfolio in Q3 2026.
- Tyro Capital Management opened 17 new positions and closed 1 in Q3 2026.
- Tyro Capital Management's portfolio value rose 27% quarter-over-quarter to $564M.
Based on Tyro Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.